ELVN
Enliven Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD36.03
+0.51 (+1.44%)
Rating:C
Company Profile
CEO
Richard A. Fair
IPO Date
2020-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$35.40
Prev. Close
$35.52
Day Low
$34.90
Day High
$36.23
52W Low
$14.79
52W High
$48.53
Market Cap
$2.19B
Volume
0.70M